Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

DMC opens R&D facility in North Carolina

by Craig Bettenhausen
November 9, 2023 | A version of this story appeared in Volume 101, Issue 37

 

Three people in PPE stand in a chemistry lab. One of them is pressing buttons on a gas chromatograph fitted with a large autosampler.
Credit: DMC Biotechnologies
DMC uses gene silencing and targeted proteolysis to optimize microbe strains for specialty chemical production.

The biobased chemicals firm DMC Biotechnologies has opened an 880 m2 R&D site in Research Triangle, North Carolina. DMC uses custom microbes to ferment a range of nutritional ingredients and other specialty chemicals. The facility will house strain and process development labs, analytical suites, and pilot-scale fermentation lines. DMC already has a lab in Boulder, Colorado, focused on isolating products after fermentation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.